Keywords: bristol-myers, squibb, take, stake, imclone, billion, reportedly
Bristol-Myers Squibb to take stake in ImClone for $1 billion?
Article | 19 September 2001
Bristol-Myers Squibb is reportedly close to buying a 19.9% stake in USbiotechnology company ImClone Systems for around $1 billion, according to the ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
- Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
- Additional indications in Japan for Roche's Avastin and Astellas' Prograf
- US Supreme Court says patent settlement can "sometimes" be illegal
